Truist Financial Corp Sells 12,512 Shares of Becton, Dickinson and Company (NYSE:BDX)

Truist Financial Corp lessened its holdings in Becton, Dickinson and Company (NYSE:BDX - Free Report) by 5.7% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 206,334 shares of the medical instruments supplier's stock after selling 12,512 shares during the quarter. Truist Financial Corp owned 0.07% of Becton, Dickinson and Company worth $47,263,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Capital Investment Advisory Services LLC bought a new stake in Becton, Dickinson and Company during the first quarter worth about $305,000. Bestgate Wealth Advisors LLC bought a new stake in Becton, Dickinson and Company during the first quarter worth about $203,000. Brookstone Capital Management lifted its position in Becton, Dickinson and Company by 12.0% during the first quarter. Brookstone Capital Management now owns 17,850 shares of the medical instruments supplier's stock worth $4,089,000 after purchasing an additional 1,907 shares during the period. Timber Creek Capital Management LLC bought a new stake in Becton, Dickinson and Company during the first quarter worth about $3,691,000. Finally, IFM Investors Pty Ltd lifted its position in Becton, Dickinson and Company by 9.0% during the first quarter. IFM Investors Pty Ltd now owns 57,878 shares of the medical instruments supplier's stock worth $13,954,000 after purchasing an additional 4,792 shares during the period. Institutional investors own 86.97% of the company's stock.

Analysts Set New Price Targets

BDX has been the subject of several recent analyst reports. Bank of America cut shares of Becton, Dickinson and Company from a "buy" rating to a "neutral" rating and set a $190.00 price objective for the company. in a research report on Thursday, May 1st. Piper Sandler downgraded Becton, Dickinson and Company from an "overweight" rating to a "neutral" rating and lowered their target price for the stock from $260.00 to $185.00 in a research note on Friday, May 2nd. Stifel Nicolaus lowered their target price on Becton, Dickinson and Company from $280.00 to $224.00 and set a "buy" rating for the company in a research note on Friday, May 2nd. Raymond James Financial downgraded Becton, Dickinson and Company from an "outperform" rating to a "market perform" rating in a research note on Friday, May 2nd. Finally, William Blair downgraded Becton, Dickinson and Company from an "outperform" rating to a "market perform" rating in a research note on Thursday, May 1st. Eight research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, Becton, Dickinson and Company currently has an average rating of "Hold" and an average price target of $219.22.

Insider Activity at Becton, Dickinson and Company

In related news, EVP Michael David Garrison sold 479 shares of the company's stock in a transaction that occurred on Wednesday, April 9th. The stock was sold at an average price of $197.28, for a total value of $94,497.12. Following the sale, the executive vice president directly owned 4,887 shares in the company, valued at $964,107.36. This represents a 8.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP David Shan sold 1,166 shares of the company's stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $171.19, for a total value of $199,607.54. Following the completion of the sale, the executive vice president owned 4,575 shares in the company, valued at $783,194.25. The trade was a 20.31% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.36% of the company's stock.

Becton, Dickinson and Company Stock Performance

Becton, Dickinson and Company stock opened at $176.16 on Monday. The business has a 50 day moving average of $173.94 and a 200-day moving average of $207.57. Becton, Dickinson and Company has a 1 year low of $163.33 and a 1 year high of $251.99. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.13 and a quick ratio of 0.64. The company has a market capitalization of $50.49 billion, a P/E ratio of 33.62, a P/E/G ratio of 1.33 and a beta of 0.25.

Becton, Dickinson and Company (NYSE:BDX - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $3.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.28 by $0.07. Becton, Dickinson and Company had a return on equity of 15.99% and a net margin of 7.28%. The company had revenue of $5.27 billion during the quarter, compared to the consensus estimate of $5.35 billion. During the same quarter in the prior year, the firm posted $3.17 earnings per share. The firm's revenue was up 4.5% compared to the same quarter last year. On average, equities research analysts predict that Becton, Dickinson and Company will post 14.43 earnings per share for the current year.

Becton, Dickinson and Company Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, June 30th. Investors of record on Monday, June 9th were issued a $1.04 dividend. This represents a $4.16 annualized dividend and a yield of 2.36%. The ex-dividend date of this dividend was Monday, June 9th. Becton, Dickinson and Company's payout ratio is presently 79.39%.

Becton, Dickinson and Company Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.